Larson Financial Group’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-38
Closed -$1.39K 2782
2024
Q2
$1.39K Hold
38
﹤0.01% 1653
2024
Q1
$1.45K Hold
38
﹤0.01% 1406
2023
Q4
$1.38K Hold
38
﹤0.01% 1415
2023
Q3
$1.15K Hold
38
﹤0.01% 1467
2023
Q2
$1.36K Hold
38
﹤0.01% 1331
2023
Q1
$1.26K Hold
38
﹤0.01% 1314
2022
Q4
$1.28K Hold
38
﹤0.01% 1258
2022
Q3
$1K Hold
38
﹤0.01% 1270
2022
Q2
$1K Hold
38
﹤0.01% 1168
2022
Q1
$2K Hold
38
﹤0.01% 942
2021
Q4
$2K Hold
38
﹤0.01% 981
2021
Q3
$2K Hold
38
﹤0.01% 803
2021
Q2
$2K Hold
38
﹤0.01% 742
2021
Q1
$2K Buy
+38
New +$2.38K ﹤0.01% 735

Larson Financial Group's BTEC Position: Q3 2024 in Review

Larson Financial Group sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 38 shares — an estimated $1.39K sold.

Larson Financial Group first reported a position in BTEC in Q1 2021 and held it in 14 quarters. The position peaked at $2K in Q1 2022. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.

  • Larson Financial Group reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
  • Larson Financial Group sold 38 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $1.39K.
  • Larson Financial Group first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2021 and held it in 14 quarters.
  • Larson Financial Group's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $2K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.

Based on Larson Financial Group's 13F filing for Q3 2024, filed 12 Nov 2024.